As of 2026-04-03, 泰瑞沙's data on the DeepSeek platform in the 医药制造 category shows: The overall mention rate is 1.43%, above the industry average by 0.9 percentage points, showing notable performance. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 泰瑞沙's overall mention rate surpasses 3 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
泰瑞沙's Mention Rate is 1.43%, lower than 0.6% of competitors
泰瑞沙's First Mention is 0.00%, lower than 0.9% of competitors
泰瑞沙's Preferred Rate is 0.00%, lower than 100.0% of competitors
泰瑞沙's Positive Rate is 0.00%, lower than 8.9% of competitors
泰瑞沙's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| KKeytruda | 7.14% | 0% | 0% | 4.29% | 0% | View Details |
| 赫赫赛汀 | 1.43% | 0% | 0% | 0% | 0% | View Details |
| 卡卡瑞利珠单抗 | 1.43% | 0% | 0% | 0% | 0% | View Details |
| 泰泰瑞沙 (Current Brand) | 1.43% | 0% | 0% | 0% | 0% | View Details |
| 立立普妥 | 0% | 0% | 0% | 0% | 0% | View Details |
| 安安宫牛黄丸 | 0% | 0% | 0% | 0% | 0% | View Details |
| 感感冒灵颗粒 | 0% | 0% | 0% | 0% | 0% | View Details |
